European Pharmaceutical Review

JUNE 26, 2024

This is compared to the company’s $3.9 (DKK Completion is expected between 2027 and 2029. Currently, worldwide, the pharmaceutical company has a five production sites in Denmark, US, France, Brazil and China, the company noted. billion investment appeared first on European Pharmaceutical Review.

Pharmaceutical Companies 104

Pharmaceutical Companies Pharmaceutical Companies 104

Pharmaceutical Technology

MAY 10, 2023

This marks a significant development in a tumultuous dispute between the pharmaceutical company and the US government. In November 2019, the government sued Gilead over the company’s alleged patent infringement of the two PrEP drugs Descovy and Truvada. GlobalData is the parent company of Pharmaceutical Technology.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies FDA 105

Pharmaceutical Technology

JUNE 22, 2008

Pharmaceutical companies dealing with the US will be closely watching the debate surrounding a proposed revision by the Senate which could see the watering down of some requirements, and an increase in others, under its Physician Payments Sunshine Act (S.2029).

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies 40

Pharmaceutical Technology

JANUARY 10, 2023

billion in 2029, with drug sales almost doubling at a compound annual growth rate (CAGR) of 11.5%. There are multiple drugs in the pipeline, predominantly me-too and biosimilar therapies, with a significant number developed in the emerging markets of India and China by domestic pharmaceutical companies for their own rapidly growing markets.

Labelling 52

Labelling Compounding Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

JUNE 16, 2023

With the adoption of digital technologies gaining traction in many industries, pharmaceutical companies must take advantage of digitalisation within its research and development (R&D) sector.

Communication 111

Communication Pharmaceutical Companies Pharmaceutical Companies Patient Care 111

Viseven

JANUARY 15, 2025

in 2029 , with a compound annual growth rate of 27.9%. In 2024 , the top 20 pharmaceutical companies have already announced that they are actively researching uses for AI in R&D. In life sciences, chatbots and virtual assistants can be used by pharmaceutical companies to improve communication with patients.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Patient Care Compounding 52

Omnicell

JANUARY 10, 2023

Starting next year, Medicare will negotiate directly with pharmaceutical companies to set the maximum fair price (MFP) for certain prescription drugs, with the application of the negotiated prices starting in 2026 for 10 negotiation-eligible drugs from Part D. In 2029 and each year after, 20 drugs from Part D or Part B will be added.

Hospitals 52

Hospitals Omnicell Pharmaceutical Companies Pharmaceutical Companies 52